SCHEMBL19396263

SCHEMBL19396263

C=CCc1c(-c2ccc(C(=O)N3CCCCC3)s2)n[nH]c1C

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
HPGD P15428 5/20 0.43
YEATS4 O95619 1/20 0.40
POLB P06746 1/20 0.40
CDK4 P11802 4/20 0.39
CCND1 P24385 4/20 0.39
LMNA P02545 2/20 0.38
HTT P42858 1/20 0.38
MAPK14 Q16539 1/20 0.38
MAPT P10636 3/20 0.37
KDM4E B2RXH2 3/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
HRH3 Q9Y5N1 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
L3MBTL3 Q96JM7 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GRM5 P41594 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1594728 0.85 ALDH1A1 (0.38) ALDH1A1HPGDYEATS4POLBCDK4
SCHEMBL19396266 0.84 HPGD (0.47) ALDH1A1HPGDYEATS4POLBCDK4
SCHEMBL19396262 0.83 LIPE (0.42) ALDH1A1HPGDYEATS4POLBCDK4
SCHEMBL19396265 0.81 ALDH1A1 (0.43) ALDH1A1HPGDYEATS4POLBLMNA
SCHEMBL1594608 0.76 YEATS4 (0.42) ALDH1A1HPGDYEATS4POLBLMNA
SCHEMBL1593562 0.75 YEATS4 (0.45) ALDH1A1HPGDYEATS4POLBCDK4
SCHEMBL19396260 0.75 ALDH1A1 (0.47) ALDH1A1HPGDYEATS4POLBLMNA
SCHEMBL1594309 0.71 CDK4 (0.38) ALDH1A1HPGDYEATS4POLBCDK4
SCHEMBL19396267 0.69 HPGD (0.46) ALDH1A1HPGDYEATS4POLBLMNA
SCHEMBL19396270 0.69 ALDH1A1 (0.46) ALDH1A1HPGDYEATS4POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170273968-A1 MAO-B INHIBITORS AND REHABILITATION DART NEUROSCIENCE, LLC 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170273968-A1 MAO-B INHIBITORS AND REHABILITATION MAOB, MAOA, HTR2B ALDH1A1 1300/4885HPGD 932/4885YEATS4 2281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.